1. The prevalence and risk factors associated with preoperative deep venous thrombosis in lung cancer surgery
- Author
-
Akira Hamada, Toshio Fujino, Masaki Shimoji, Junichi Soh, Masato Chiba, Kenichi Suda, Takamasa Koga, Shuta Ohara, Kenji Tomizawa, Toshiki Takemoto, Tetsuya Mitsudomi, and Masaya Nishino
- Subjects
medicine.medical_specialty ,Lung cancer surgery ,COPD ,business.industry ,General Medicine ,medicine.disease ,University hospital ,Logistic regression ,03 medical and health sciences ,Venous thrombosis ,0302 clinical medicine ,Surgical oncology ,030220 oncology & carcinogenesis ,Internal medicine ,D-dimer ,medicine ,030211 gastroenterology & hepatology ,Surgery ,cardiovascular diseases ,Lung cancer ,business - Abstract
Few studies have so far focused on the preoperative presence of venous thromboembolism (VTE) in lung cancer patients undergoing surgery. In this study, we investigated the prevalence and risk factors for preoperative deep venous thrombosis (DVT) in patients scheduled to undergo lung cancer surgery. Between June 2013 and December 2018, 948 consecutive patients underwent lung cancer surgery in Kindai University Hospital. Four patients did not undergo screening for DVT; thus, 944 patients were enrolled in this study. Preoperatively, venous ultrasonography of the lower extremities was performed in patients deemed at risk for DVT, and the prevalence and risk factors for preoperative DVT were examined. Ninety-one patients (9.6%) were diagnosed with preoperative DVT, and postoperative symptomatic pulmonary thromboembolism occurred in one patient (0.11%). A multivariable logistic regression analysis demonstrated that female sex, age ≥ 72 years, history of VTE, a Wells score ≥ 2 points, chronic obstructive pulmonary disease (COPD), and lower hemoglobin levels were significantly associated with preoperative DVT. Female sex, age ≥ 72 years, history of VTE, Wells score ≥ 2 points, COPD, and lower hemoglobin levels were identified to be independent risk factors for preoperative DVT. Monitoring for these risk factors and management considering them should help improve the outcomes after lung cancer surgery.
- Published
- 2021